JP2021527418A5 - - Google Patents
Info
- Publication number
- JP2021527418A5 JP2021527418A5 JP2020570457A JP2020570457A JP2021527418A5 JP 2021527418 A5 JP2021527418 A5 JP 2021527418A5 JP 2020570457 A JP2020570457 A JP 2020570457A JP 2020570457 A JP2020570457 A JP 2020570457A JP 2021527418 A5 JP2021527418 A5 JP 2021527418A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- domain
- polynucleotide
- sequence
- raav
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024127744A JP7879196B2 (ja) | 2018-06-18 | 2024-08-02 | ジストログリカノパチーおよびラミニン欠損筋ジストロフィーを治療するための組換えアデノ随伴ウイルス生成物および方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862686522P | 2018-06-18 | 2018-06-18 | |
| US62/686,522 | 2018-06-18 | ||
| PCT/US2019/037769 WO2019246125A1 (en) | 2018-06-18 | 2019-06-18 | Recombinant adeno-associated virus products and methods for treating dystroglycanopathies and laminin-deficient muscular dystrophies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024127744A Division JP7879196B2 (ja) | 2018-06-18 | 2024-08-02 | ジストログリカノパチーおよびラミニン欠損筋ジストロフィーを治療するための組換えアデノ随伴ウイルス生成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021527418A JP2021527418A (ja) | 2021-10-14 |
| JP2021527418A5 true JP2021527418A5 (enExample) | 2022-06-28 |
| JP7534961B2 JP7534961B2 (ja) | 2024-08-15 |
Family
ID=67263074
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020570457A Active JP7534961B2 (ja) | 2018-06-18 | 2019-06-18 | ジストログリカノパチーおよびラミニン欠損筋ジストロフィーを治療するための組換えアデノ随伴ウイルス生成物および方法 |
| JP2024127744A Active JP7879196B2 (ja) | 2018-06-18 | 2024-08-02 | ジストログリカノパチーおよびラミニン欠損筋ジストロフィーを治療するための組換えアデノ随伴ウイルス生成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024127744A Active JP7879196B2 (ja) | 2018-06-18 | 2024-08-02 | ジストログリカノパチーおよびラミニン欠損筋ジストロフィーを治療するための組換えアデノ随伴ウイルス生成物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12668617B2 (enExample) |
| EP (1) | EP3807309A1 (enExample) |
| JP (2) | JP7534961B2 (enExample) |
| AU (2) | AU2019288291B2 (enExample) |
| CA (1) | CA3104471A1 (enExample) |
| WO (1) | WO2019246125A1 (enExample) |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05506435A (ja) * | 1990-01-30 | 1993-09-22 | ラ ホヤ キャンサー リサーチ ファウンデーション | メロシン、それをコードする核酸、フラグメントおよびその使用 |
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| EP0733103B1 (en) | 1993-11-09 | 2004-03-03 | Targeted Genetics Corporation | Generation of high titers of recombinant aav vectors |
| DE69433922T2 (de) | 1993-11-09 | 2005-07-28 | Medical College Of Ohio, Toledo | Stabile zellinie, die in der lage ist, das replikationsgen des adenoassoziertenvirus zu exprimieren |
| US5658785A (en) | 1994-06-06 | 1997-08-19 | Children's Hospital, Inc. | Adeno-associated virus materials and methods |
| US5856152A (en) | 1994-10-28 | 1999-01-05 | The Trustees Of The University Of Pennsylvania | Hybrid adenovirus-AAV vector and methods of use therefor |
| WO1996017947A1 (en) | 1994-12-06 | 1996-06-13 | Targeted Genetics Corporation | Packaging cell lines for generation of high titers of recombinant aav vectors |
| FR2737730B1 (fr) | 1995-08-10 | 1997-09-05 | Pasteur Merieux Serums Vacc | Procede de purification de virus par chromatographie |
| JPH11511326A (ja) | 1995-08-30 | 1999-10-05 | ジエンザイム コーポレイション | アデノウィルスおよびａａｖの精製 |
| JPH11514853A (ja) | 1995-09-08 | 1999-12-21 | ジエンザイム コーポレイション | 遺伝子治療のための改良されたａａｖベクター |
| US5910434A (en) | 1995-12-15 | 1999-06-08 | Systemix, Inc. | Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant |
| EP1696036B1 (en) | 1996-09-06 | 2010-04-21 | The Trustees of The University of Pennsylvania | Use of recombinant adeno-associated virus in the manufacture of a medicament for gene therapy via muscle cells |
| CA2995542A1 (en) | 1997-09-05 | 1999-03-11 | Genzyme Corporation | Methods for generating high titer helper-free preparations of recombinant aav vectors |
| US6566118B1 (en) | 1997-09-05 | 2003-05-20 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| US6258595B1 (en) | 1999-03-18 | 2001-07-10 | The Trustees Of The University Of Pennsylvania | Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| JP2004514407A (ja) | 2000-04-28 | 2004-05-20 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | 異種キャプシド中にシュードタイピングされたａａｖ５キャプシドおよびａａｖ５ベクターを含む組換えａａｖベクター |
| WO2002053703A2 (en) | 2001-01-05 | 2002-07-11 | Children's Hospital, Inc. | Aav2 vectors and methods |
| US20110166081A1 (en) | 2009-12-03 | 2011-07-07 | University Of Iowa Research Foundation | Alpha-dystroglycan as a Protein Therapeutic |
| US9434928B2 (en) | 2011-11-23 | 2016-09-06 | Nationwide Children's Hospital, Inc. | Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides |
| DE102012007232B4 (de) | 2012-04-07 | 2014-03-13 | Susanne Weller | Verfahren zur Herstellung von rotierenden elektrischen Maschinen |
| JP2015092462A (ja) | 2013-09-30 | 2015-05-14 | Tdk株式会社 | 正極及びそれを用いたリチウムイオン二次電池 |
| WO2015141521A1 (ja) | 2014-03-21 | 2015-09-24 | 株式会社日立国際電気 | 基板処理装置、半導体装置の製造方法及び記録媒体 |
| JP6197169B2 (ja) | 2014-09-29 | 2017-09-20 | 東芝メモリ株式会社 | 半導体装置の製造方法 |
| KR102799163B1 (ko) | 2015-09-17 | 2025-04-21 | 더 리서치 인스티튜트 앳 네이션와이드 칠드런스 하스피탈 | Galgt2 유전자 치료 방법 및 물질 |
| WO2017181011A1 (en) | 2016-04-15 | 2017-10-19 | Research Institute At Nationwide Children's Hospital | Adeno-associated virus vector delivery of microrna-29 to treat muscular dystrophy |
| WO2018151841A1 (en) * | 2017-02-17 | 2018-08-23 | Sanofi | Multispecific binding molecules having specificity to dystroglycan and laminin-2 |
-
2019
- 2019-06-18 JP JP2020570457A patent/JP7534961B2/ja active Active
- 2019-06-18 AU AU2019288291A patent/AU2019288291B2/en active Active
- 2019-06-18 CA CA3104471A patent/CA3104471A1/en active Pending
- 2019-06-18 US US17/254,055 patent/US12668617B2/en active Active
- 2019-06-18 WO PCT/US2019/037769 patent/WO2019246125A1/en not_active Ceased
- 2019-06-18 EP EP19739791.2A patent/EP3807309A1/en active Pending
-
2024
- 2024-08-02 JP JP2024127744A patent/JP7879196B2/ja active Active
- 2024-11-01 AU AU2024259685A patent/AU2024259685A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102298579B1 (ko) | 캡시드-변형된 raav3 벡터 조성물, 및 인간 간암의 유전자 요법에서의 용도 | |
| EP2623605B1 (en) | RAAV vector compositions having tyrosine-modified capsid proteins and methods for use | |
| CA2407309A1 (en) | Dna sequences encoding dystrophin minigenes and methods of use thereof | |
| JP2020510428A5 (enExample) | ||
| FI3684423T3 (fi) | Adenoassesioidun viruksen kapsidivariantteja ja niiden käyttömenetelmiä | |
| JP2021534809A (ja) | Ａａｖカプシドの向性の再指向化 | |
| AU2021236481A1 (en) | Evasion of neutralizing antibodies by a recombinant adeno-associated virus | |
| JP2020510429A5 (enExample) | ||
| JP2019515663A5 (enExample) | ||
| CN110950934B (zh) | 一种腺相关病毒衣壳蛋白、载体及其构建方法与应用 | |
| RU2019126509A (ru) | Выделенный модифицированный белок VP1 капсида аденоассоциированного вируса 5 серотипа (AAV5), капсид и вектор на его основе | |
| JP2018527365A5 (enExample) | ||
| WO2019227219A1 (en) | Adeno-associated viral vector-mediated gene therapy for treating fragile x-associated disorders | |
| CN116096904A (zh) | 改进的aav-abcd1构建体和用于治疗或预防肾上腺脑白质营养不良(ald)和/或肾上腺脊髓神经病(amn)的用途 | |
| RU2760301C1 (ru) | Вакцина на основе AAV5 для индукции специфического иммунитета к вирусу SARS-CoV-2 и/или профилактики коронавирусной инфекции, вызванной SARS-CoV-2 | |
| JP2023534293A5 (enExample) | ||
| JP2021534794A5 (enExample) | ||
| AU2021331947A1 (en) | Aav5-based vaccine against sars-cov-2 | |
| JP2024528997A (ja) | 放射線誘発性唾液機能低下を予防するためのａｑｐ１遺伝子療法 | |
| CN117003833A (zh) | 肝脏特异性的腺相关病毒血清型及应用 | |
| JP2024537797A5 (enExample) | ||
| RU2856244C2 (ru) | Вакцина на основе AAV5 для индукции специфического иммунитета к вирусу SARS-CoV-2 и/или профилактики коронавирусной инфекции, вызванной SARS-CoV-2 | |
| CN112695032B (zh) | 一种启动子pLRRK2及其应用 | |
| CN115160410A (zh) | 新型肌肉高效亲和腺相关病毒血清型及相关应用 | |
| WO2024249438A1 (en) | Copiparvovirus genetic vector platform |